Child with recurrent pneumonias, steatorrhea, and failure to thrive but a negative sweat chloride test

The advisors debated whether the negative sweat test rules out cystic fibrosis or points to an alternative diagnosis like Shwachman-Diamond syndrome. Two camps emerged: one arguing that CF sweat tests have a 2-5% false negative rate and warrant genetic testing, the other insisting the negative result means pursuing Shwachman-Diamond with basic blood work first. The core tension is whether to chase the statistical possibility of missed CF or follow the diagnostic algorithm pointing away from it.

The Auditor ADVISE
Let's lock down what we actually know from the parent. They stated the child has recurrent pneumonias, steatorrhea, and failure to thrive — that's the classic triad screaming cystic fibrosis. But here's the wrench: the sweat chloride came back negative. Before anyone starts throwing out exotic diagnoses, we need to verify that test was done properly and consider that false negatives happen in about 1-5% of CF cases according to the literature.

Dr. Elena Rossi PUSHBACK
The Auditor, you're anchoring on CF because the triad fits, but that negative sweat test isn't just a wrench—it's a red flag that we're looking at the wrong disease. I've seen this exact presentation turn out to be Shwachman-Diamond syndrome, where you get pancreatic insufficiency with steatorrhea and recurrent infections from neutropenia, not from thick mucus. The briefing specifically mentions ruling out CF with sweat chloride before considering Shwachman, and that's exactly where we are now.

Dr. Rachel Weinberg WARN
Elena, you're making the exact mistake that delays CF diagnoses by years. The sweat test has a 2-5% false negative rate in genetically confirmed CF patients—that's not a red flag to rule out CF, it's a red flag to order CFTR sequencing and nasal potential difference testing immediately. I just saw a 7-year-old last month with Shwachman-Diamond in my CF clinic, and the neutropenia was obvious on basic labs—if this child had Shwachman, the parent would've mentioned recurrent skin infections and neutropenic fevers, not just pneumonias.

The Contrarian WARN
Rachel, you're betting the house on CF because the false negative rate exists. But I've watched clinicians chase that 2-5% tail risk right past the actual diagnosis for months. The briefing explicitly says to rule out CF with sweat chloride before moving to Shwachman — we're at that exact fork in the road now. You're pushing expensive genetic panels when we haven't even checked a basic CBC to see if this kid is neutropenic, which would confirm Shwachman in 48 hours for $50.

The doctors debated whether to pursue cystic fibrosis testing immediately or screen for other causes of recurrent pneumonia first. Dr. Chen and others argued for checking immune deficiencies like CVID since the pneumonias lack typical CF pathogens (Pseudomonas, Staph aureus), while Dr. Rossi suggested malabsorption conditions like celiac disease could cause secondary immunocompromise. Dr. Weinberg warned that delaying CF genetic testing risks irreversible lung damage (bronchiectasis), especially since normal sweat tests can miss certain CFTR mutations.

Dr. Sarah Chen REFRAME
Everyone's debating sweat test accuracy, but nobody's asking about the pneumonias themselves. If this were truly CF lung disease, we'd expect Pseudomonas or Staph aureus colonization by now—those pathogens don't just show up in random respiratory infections. The briefing mentions that recurrent bacterial pneumonias usually represent an anatomic defect, aspiration, or immune deficiency like common variable immunodeficiency. I just diagnosed my third CVID patient this year who presented exactly like this—recurrent sinopulmonary infections that everyone assumed was asthma until we checked immunoglobulins.

The Auditor FACTCHECK
Sarah, you're right to bring up common variable immunodeficiency—the web data I pulled confirms CVID presents with recurrent sinopulmonary infections from encapsulated bacteria like S. pneumoniae and H. influenzae, exactly what we'd expect here. But here's what nobody's addressing: we don't actually know what pathogens are causing these pneumonias. The parent only said 'recurrent pneumonias'—we're all speculating about Pseudomonas colonization or neutropenic infections without a single culture result to back it up.

Dr. Elena Rossi PUSHBACK
The Auditor, you're right we don't have culture data, but you're missing the forest for the trees. The pattern matters more than the specific bug. Recurrent pneumonias plus steatorrhea plus failure to thrive is a triad that screams malabsorption-driven immunocompromise, not primary lung disease. I've seen three cases of celiac disease present exactly this way—chronic malnutrition tanks your IgA levels, you can't mount mucosal immune responses, and you get pneumonia after pneumonia while everyone chases exotic diagnoses. The briefing explicitly mentions immunodeficiency disorders resulting in malabsorption requiring staged screening tests before committing to CF or Shwachman.

Dr. Rachel Weinberg WARN
Contrarian, your $50 CBC sounds efficient, but here's what actually happens when you delay CF genetic testing in kids like this: they develop irreversible bronchiectasis while you're chasing Shwachman down a garden path. I just saw this exact scenario three months ago—7-year-old with normal sweat chloride, everyone assumed it ruled out CF, turned out to have two class IV CFTR mutations. By the time genetics came back, CT showed basilar bronchiectasis that will never reverse. The briefing says sweat test must be confirmed by CFTR gene identification when clinical presentation screams CF, and this triad absolutely screams it.

The debate centered on whether to pursue immediate genetic testing for cystic fibrosis (CF) versus a staged workup starting with cheaper screening tests. The Contrarian argued that rushing to expensive genetic panels misses fixable causes like vitamin deficiencies or IgA deficiency, while Dr. Weinberg countered that delayed CF diagnosis leads to irreversible lung damage (bronchiectasis). Dr. Rossi proposed the child might have two concurrent conditions—an autoimmune gut problem plus a separate immune deficiency—rather than one unifying diagnosis.

The Contrarian WARN
Rachel, I've seen this exact rush-to-genetics playbook blow up twice. Both times the kid had something fixable—one was vitamin E deficiency from chronic cholestasis, the other was selective IgA deficiency with secondary malnutrition—and both families got a $3,000 CFTR panel bill while the actual problem sat untreated for another six weeks. The briefing says immunodeficiency disorders can cause malabsorption requiring staged screening tests before committing to CF workup. Staged means hierarchical, not shotgun. Your bronchiectasis case is the exception being used to justify making the expensive test the rule.

The Auditor FACTCHECK
Elena, I checked the literature on celiac presenting with recurrent pneumonias—you're right that it can cause failure to thrive and steatorrhea, but the evidence shows celiac typically presents with diarrhea, weight loss, and malabsorption symptoms, not recurrent bacterial pneumonias as a primary feature. The briefing mentions immunodeficiency causing malabsorption, but celiac causing secondary immunocompromise leading to multiple pneumonias isn't documented in the research I pulled. You might be conflating two separate pathways here.

Dr. Elena Rossi PUSHBACK
You're right that celiac alone doesn't cause recurrent pneumonias—I'm not saying it does. What I'm saying is this child could have two concurrent problems: an autoimmune enteropathy causing the GI symptoms and a separate primary immunodeficiency causing the lung infections. I've seen this twice in my career—kids with celiac plus selective IgA deficiency, which the briefing confirms exists. Everyone's treating this like it has to be one unifying diagnosis, but sometimes kids just get dealt a bad hand with multiple pathologies running in parallel.

Dr. Rachel Weinberg WARN
Elena, you're describing concurrent pathologies, but that's exactly how we miss CF in clinic—by assuming multiple separate diagnoses when it's one disease with variable presentation. I just reviewed a 7-year-old last month with Shwachman-Diamond who we'd been treating for two years because everyone said 'the sweat test was normal, it can't be CF.' Turned out she had a rare CFTR mutation that produces near-normal sweat chloride but devastating pancreatic and pulmonary disease. By the time genetics came back, she already had early bronchiectasis on CT that's permanent.

The advisors debated whether the child's negative sweat test is reassuring or misleading. Dr. Weinberg revealed she runs a tertiary referral center that sees children with false-negative sweat tests after community doctors stopped investigating, creating selection bias that makes CF seem more common than it is. The group split between pursuing expensive genetic testing immediately versus starting with cheaper tests for common causes, with one advisor suggesting empirical pancreatic enzyme treatment while waiting for results.

The Auditor PUSHBACK
Rachel, you just told us about a 7-year-old with Shwachman-Diamond you'd been treating for two years who turned out to have CF. Then you told us about a different 7-year-old three months ago with CF missed by normal sweat test. That's two separate kids in your recent practice with false-negative sweat tests—which would be statistically bizarre given the 2-5% false negative rate unless you're running a tertiary CF referral center. The briefing says nothing about how common this actually is in general pediatrics. Are we making decisions based on pattern recognition from a biased sample?

Dr. Rachel Weinberg WARN
You're right that two recent cases sounds statistically bizarre—except my clinic is a tertiary referral center specifically for kids with atypical presentations after their community pediatricians already ruled out CF with normal sweat tests. That selection bias is exactly the problem: community docs see a negative sweat chloride and stop there, so the 2-5% with false negatives all end up funneled to specialists like me after they've already developed irreversible changes. If this parent walks away today thinking the negative sweat test settled anything, we've just set them up to become my next referral in eighteen months when the kid has bronchiectasis on CT.

Dr. Elena Rossi WARN
Rachel, your tertiary center sees the disasters—but that creates therapeutic momentum toward the most aggressive workup regardless of pretest probability. I've watched colleagues order $3,000 CFTR panels on every kid with loose stools and a cough because they're terrified of missing the zebra. The real malpractice here isn't missing rare CF—it's draining this family's resources chasing statistical noise when a $200 workup for celiac, IgA deficiency, and basic immunoglobulins would catch the most common fixable causes in two weeks. If those come back normal, then we escalate.

The Contrarian WARN
Everyone's debating which test to run first, but nobody's asking what happens if the parent can't afford any of this. I've watched families drain savings on specialist visits and genetic panels while the kid keeps losing weight because nobody prescribed pancreatic enzymes empirically. The briefing says CF was initially recognized as a cause of failure to thrive in infants—meaning kids were dying before we had fancy tests. Start empirical pancreatic enzyme replacement today while you wait for results. If the steatorrhea stops, you've bought time and confirmed exocrine insufficiency without bankrupting them.

The advisors debated what to do after a negative sweat test in a child with signs of CF. Dr. Chen recommended starting pancreatic enzymes immediately while running cheaper tests for celiac and immune issues. The Contrarian warned that families often stop investigating after a negative sweat test, allowing damage to progress. Dr. Rossi noted that clinical guidelines don't specify next steps after a negative sweat test, leaving families in diagnostic uncertainty. The Auditor argued the briefing does provide guidance—suggesting CF is unlikely and pointing toward immune workup instead.

Dr. Sarah Chen ADVISE
The briefing explicitly states that for diagnosis, a positive sweat test must be confirmed by repeating it OR by identifying two CFTR mutations OR by abnormal nasal epithelium studies—but it says nothing about what to do when the sweat test is negative. That's the diagnostic gap we're standing in right now. My recommendation: start pancreatic enzyme replacement empirically today while running a parallel workup for celiac IgA/tTG, total immunoglobulins, and pneumococcal titers—all of which cost under $400 combined and will be back in a week. If the steatorrhea resolves on enzymes, you've confirmed exocrine insufficiency and bought time to decide whether genetic testing is worth the cost.

The Contrarian WARN
Everyone here is debating what test to run next, but nobody's asking whether this parent has already been told by three different doctors that everything's fine because the sweat test was negative. I've watched families stop pushing after the reassurance of a negative gold standard test—they blame themselves for the kid's weight, they accept the pneumonias as bad luck, and by the time someone finally orders the right workup, the damage is permanent. The real risk isn't ordering the wrong test first—it's that this parent walks out of their pediatrician's office today thinking the negative sweat chloride means they can relax.

Dr. Elena Rossi WARN
Here's what nobody's mentioned: the briefing says a positive sweat test must be confirmed by repeating it or finding two CFTR mutations, but gives zero guidance on what confirmation looks like when the sweat test is negative. That's not an oversight—it's because we genuinely don't have a validated next step. So whether this parent pursues genetic testing or starts with cheaper screening, they're walking into diagnostic uncertainty either way, and we need to be honest that there's no algorithm to follow here.

The Auditor PUSHBACK
Sarah, you just claimed the briefing says nothing about what to do when the sweat test is negative, but that's not accurate. The briefing explicitly states 'a sweat chloride test result within normal limits suggests that CF is unlikely.' That's guidance—it's telling us to look elsewhere. The briefing also lists a diagnostic algorithm for immunodeficiency in children with recurrent GI symptoms and failure to thrive, which is exactly what we're looking at here. We're not in some diagnostic void—the evidence is pointing us toward immune workup, not chasing statistical ghosts.